Adelaide has been a hub of health-related science for decades; now, that expertise – combined with our strengths in education and training, IT and manufacturing – is stimulating life-saving discoveries in pharmaceuticals, medical devices, clinical trials and commercialisation, and digital training and healthcare.
Adelaide BioMed City is one of the largest life-sciences clusters in the southern hemisphere. Featuring 25,000 square metres of purpose-built research facilities in the South Australian Health and Medical Research Institute, the new Royal Adelaide Hospital and new University of Adelaide medical training facilities.
More than 8000 staff – including 1500 global medical researchers – and 6000 students will be accommodated in the facilities.
At the time of opening, SAHMRI executive director Professor Steve Wesselingh said the centre's potential was unlimited.
"SAHMRI will be a vibrant, globally recognised research institute which harnesses dynamic collaborations to deliver tangible health outcomes and community impacts not just in Australia, but across the world," he said.
SAHMRI's specialist fields of interest are: heart health, Aboriginal health, mind and brain, cancer, healthy mothers, babies and children, infection and immunity and nutrition and metabolism.
The State Government has established Health Industries SA (HealthInSA) to identify, explore and promote growth opportunities in the sector.
These elements make Adelaide a leader in this field and there are many opportunities for private investment. Investors can play a critical role in the development of health services, medical devices, pharmaceutical industries and the testing, refining and commercialisation of health research and technologies.
There are plans for a second SAHMRI wing that would almost double the floor space of the facility and accommodate research pertaining to the CSIRO's nutrition and health sciences program. This facility would include a proton therapy treatment unit and host a clinical trials unit among other features.